Orchid Pharma P/E Ratio
Orchid Pharma (ORCHPHARMA) P/E ratio is not applicable — EPS (TTM) ₹19.65, 1 consecutive loss quarter. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Consecutive Loss Quarters: 1
Current EPS: ₹19.65
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -1.13 | -6 | Loss |
| Mar 2025 | 4.40 | 22 | Profit |
| Jun 2025 | 2.94 | 15 | Profit |
| Dec 2025 | -2.49 | -13 | Loss |
| Sept 2024 | 5.37 | 27 | Profit |
| Mar 2024 | 6.81 | 33 | Profit |
| Jun 2024 | 5.79 | 29 | Profit |
| Dec 2024 | 4.10 | 21 | Profit |
Healthcare Peers with Valid P/E Ratios — ORCHPHARMA Comparison
Healthcare sector average P/E 48.32, median 28.77 — ORCHPHARMA excluded (negative EPS).
Sector Average PE
48.32
Sector Median PE
28.77
Lowest PE
0.97
Profitable Companies
193
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see ORCHPHARMA stock price BSE.
- Browse ORCHPHARMA balance sheet details for revenue, profit, balance sheet and cash flow data.
- Analyse ORCHPHARMA shareholder distribution to track promoter, FII and institutional holdings.